The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 30, 2013
Filed:
Mar. 08, 2011
Pia M. Challita-eid, Encino, CA (US);
Arthur B. Raitano, Los Alamitos, CA (US);
Mary Faris, Los Angeles, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Robert Kendall Morrison, Santa Monica, CA;
Wangmao GE, Tampa, FL (US);
Aya Jakobovits, Beverly Hills, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Arthur B. Raitano, Los Alamitos, CA (US);
Mary Faris, Los Angeles, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Karen Jane Meyrick Morrison, Santa Monica, CA (US);
Robert Kendall Morrison, Santa Monica, CA;
Wangmao Ge, Tampa, FL (US);
Aya Jakobovits, Beverly Hills, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 162P1E6) and its encoded protein, and variants thereof, are described wherein 162P1E6 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 162P1E6 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 162P1E6 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 162P1E6 can be used in active or passive immunization.